Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management

Renal Colic Clinical Trial

Official title:

A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02187614
• Other study ID #: IRB Number: 14-00059
• Secondary ID: Hamad Medical Co
• Status: Completed
• Phase: Phase 4
• First received: July 7, 2014
• Last updated: March 17, 2015
• Start date: August 2014
• Est. completion date: March 2015

Study information

• Verified date: March 2015
• Source: Hamad Medical Corporation
• Contact: n/a
• Is FDA regulated: No
• Health authority: Qatar: Joint Institutional Review BoardQatar: Supreme Council Of Health Qatar
• Study type: Interventional

Clinical Trial Summary

Abdominal pain is one of the most common presentations to an emergency department (ED). Among patients presenting with abdominal pain, a common diagnosis in the Middle East is renal colic (urolithiasis or Kidney stones). As the patients with renal colic writhe around in agonizing pain, the first priority in an ED from a patient's perspective is fast and safe analgesia and to be pain free as early as possible. There are variations in physician preference to choose initial analgesic drug for managing such pain. Commonly used drugs are:

• Opioids such as Morphine or Fentanyl

• Non steroidal drugs such as Diclofenac, Ketorolac or Brufen

• and Paracetamol intravenous injection.

A robust evidence in comparison of diclofenac versus morphine and paracetamol is lacking. This study is design to obtain data on efficacy of these three drugs within 30 minutes in a non inferiority trail.

Description:

This will be a double blind RCT, where participants will be enrolled consecutively after meeting eligibility criteria and obtaining a written informed consent. They will be assign to one of the three study arms by computer generated randomization process. The study packets will be prepared by a dedicated nurse or pharmacist who will not a part of investigating team. Each Patients will receive one analgesic drug (active drug) and two placebos. Drugs will be given as one intramuscular injection and two intravenous solutions.

Pain score will be recorded using NRS at 0, 30, 60, and 90 minutes. Data will be collected on standard Data collection form. Each participant will receive analgesia from study packet which contains, one active drug and two placebos to be administer as one intramuscular and two intravenous solutions. At any given time every patient will receive one analgesia from either Diclofenac, Paracetamol or Morphine. If patient pain does not respond to initial treatments, at 30 minutes a rescue analgesia in form of morphine will be administered till patient is pain free or NRS<=2 or adverse event to morphine.

Based on the results of previous studies (1-3), proportion of patients achieving more than 50% pain reduction, is between 65-75% for diclofenac, morphine and paracetamol when compared with other drugs. In each group, 437 patients are required to detect a difference of 10% in primary outcome, in a superiority trial with power (1-beta) of 90% and significance level (alpha) of 5% in this study. Considering 15% extra, total sample size required in this superiority trial will be 1507 patients in total.

Data will be collected on a standard data recording form and it will be converted to electronic excel sheet hiding patient identifiable details. Continuous variables will be presented as mean with standard deviation (SD). Categorical variables will be calculated as proportions and presented with 95% Confidence interval (CI). Statistical analyses will be undertaken using Stata 12.0 (College Station, Texas).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1645
• Est. completion date: March 2015
• Est. primary completion date: February 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Age >=18 years and < 65 years

• Acute onset, one side flank or loin pain, with or without radiation to groin or genital areas.

• Pain intensity on NRS more than or equal to 4. (Moderate to Severe Pain)

• Diagnosis confirmed by non contrast CT KUB within the ED visit.

Exclusion Criteria:

• Traumatic flank pain

• Pregnancy

• Known renal failure or impairment

• Known allergy to morphine, diclofenac or paracetamol

• Bronchial asthma

• Previously enrolled in the study.

• Use of any analgesia in last 6 hour.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Calculi
• Colic
• Renal Colic
• Urinary Calculi

Intervention

Drug:
• Diclofenac

• Morphine

• Paracetamol

• Placebos

Locations

Country	Name	City	State
Qatar	Emergency Department, Hamad General Hospital.	Doha

Sponsors (1)

Lead Sponsor	Collaborator
Hamad Medical Corporation

Country where clinical trial is conducted

Qatar, 

References & Publications (3)

Behzadnia MJ, Javadzadeh HR, Saboori F. Time of admission, gender and age: challenging factors in emergency renal colic - a preliminary study. Trauma Mon. 2012 Fall;17(3):329-32. doi: 10.5812/traumamon.6800. Epub 2012 Oct 10. — View Citation

Grissa MH, Claessens YE, Bouida W, Boubaker H, Boudhib L, Kerkeni W, Boukef R, Nouira S. Paracetamol vs piroxicam to relieve pain in renal colic. Results of a randomized controlled trial. Am J Emerg Med. 2011 Feb;29(2):203-6. doi: 10.1016/j.ajem.2009.09.019. Epub 2010 Oct 8. — View Citation

Shaden Salameh; Nurit Hiller; Meir Antopolsky; Fedaa Ghanem; Yigaal Abramovitz; Ruth Stalnikowics. Diclofenac versus Tramadol in the Treatment of Renal Colic: A Prospective, Randomized Trial. The Open Emergency Medicine Journal. 2011; 4: 9-13.

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	adverse event rate		Within 14 days of ED visit	Yes
Other	total analgesia requirement to get pain score (NRS) less than or equal to 2.		by 90 minutes	No
Primary	The proportion of patients achieving a reduction of >50% on Numerical Rating Scale (NRS-11) from the initial NRS recorded at the end of 30 minutes in each study arm.		at 30 minutes after analgesia	No
Secondary	reduction in mean NRS		at 30, 60 and 90 minutes after analgesia	No